CoverageForm 410-K10-Q8-K13D13G13F

Estrella Immunopharma, Inc.

ESLACIK 0001844417 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone 0.0018

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Estrella Immunopharma, Inc.

NameRolesFilings
Yang Weiguang
-
1

Showing 11-11 of 11

PrevPage 3 of 3

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Estrella Immunopharma, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Xu Jiandong3100%+45.8%+31.9%+100.0%+5.6%

All filings

12 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue